GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+14.11%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$374M
AUM Growth
+$374M
(+13%)
Cap. Flow
+$9.27M
Cap. Flow
% of AUM
2.48%
Top 10 Holdings %
Top 10 Hldgs %
34.22%
Holding
89
New
22
Increased
17
Reduced
12
Closed
26
Top Buys
| 1 |
Neurocrine Biosciences
NBIX
|
$13M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$9.84M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$9.53M |
| 4 |
ELGX
Endologix Inc
ELGX
|
$9.41M |
| 5 |
Enanta Pharmaceuticals
ENTA
|
$9.24M |
Top Sells
| 1 |
Abbott
ABT
|
$15.4M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$14.1M |
| 3 |
CELG
Celgene Corp
CELG
|
$12.7M |
| 4 |
SHPG
Shire pic
SHPG
|
$12.2M |
| 5 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$7.61M |
Sector Composition
| 1 | Healthcare | 86.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
26
DELISTED
Sage Therapeutics
SAGE
| $7.11M | 1.32% |
100,000
-100,000
| -50% | -$7.11M |
|
|
NVDQ
27
DELISTED
Novadaq Technologies Inc.
NVDQ
| $7.01M | 1.31% |
+900,000
| New | +$7.01M |
|
|
RARX
28
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $6.39M | 1.19% |
300,000
+225,000
| +300% | +$4.79M |
|
|
ACOR
29
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $6.3M | 1.17% |
300,000
+280,000
| +1,400% | +$5.88M |
|
|
KTWO
30
DELISTED
K2M Group Holdings, Inc
KTWO
| $5.85M | 1.09% |
+285,000
| New | +$5.85M |
|
|
WMGI
31
DELISTED
Wright Medical Group Inc
WMGI
| $5.76M | 1.07% |
185,000
+10,000
| +6% | +$311K |
|
32
Prothena Corp
PRTA
$446M
| $5.58M | 1.04% |
+100,000
| New | +$5.58M |
|
|
NXTM
33
DELISTED
NxStage Medical Inc.
NXTM
| $5.37M | 1% |
+200,000
| New | +$5.37M |
|
|
SHPG
34
DELISTED
Shire pic
SHPG
| $5.23M | 0.97% |
30,000
-70,000
| -70% | -$12.2M |
|
|
ENTL
35
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
| $5.18M | 0.96% |
375,000
+175,000
| +88% | +$2.42M |
|
36
Incyte
INCY
$17B
| $4.68M | 0.87% |
35,000
+22,000
| +169% | +$2.94M |
|
|
SPNC
37
DELISTED
Spectranetics Corp
SPNC
| $4.51M | 0.84% |
155,000
-180,000
| -54% | -$5.24M |
|
|
BPMC
38
DELISTED
Blueprint Medicines
BPMC
| $4M | 0.75% |
+100,000
| New | +$4M |
|
|
ZGNX
39
DELISTED
Zogenix, Inc.
ZGNX
| $3.96M | 0.74% |
365,000
+140,000
| +62% | +$1.52M |
|
40
Collegium Pharmaceutical
COLL
$1.23B
| $3.77M | 0.7% |
+375,000
| New | +$3.77M |
|
41
Neurogene
NGNE
$270M
| $3.76M | 0.7% |
225,000
| – | – |
|
42
Rigel Pharmaceuticals
RIGL
$696M
| $3.64M | 0.68% |
1,100,000
+400,000
| +57% | +$1.32M |
|
43
IRIDEX
IRIX
$23.1M
| $2.97M | 0.55% |
250,000
+50,000
| +25% | +$594K |
|
|
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.44M | 0.45% |
+150,000
| New | +$2.44M |
|
|
DERM
45
DELISTED
Dermira, Inc.
DERM
| $2.22M | 0.41% |
+65,000
| New | +$2.22M |
|
|
CBAY
46
DELISTED
Cymabay Therapeutics
CBAY
| $2.15M | 0.4% |
+500,000
| New | +$2.15M |
|
|
CFMS
47
DELISTED
Conformis, Inc. Common Stock
CFMS
| $2.09M | 0.39% |
+400,000
| New | +$2.09M |
|
48
PTC Therapeutics
PTCT
$4.32B
| $1.97M | 0.37% |
+200,000
| New | +$1.97M |
|
|
STML
49
DELISTED
Stemline Therapeutics, Inc.
STML
| $1.92M | 0.36% |
+225,000
| New | +$1.92M |
|
50
Invesco CurrencyShares Swiss Franc Trust
FXF
$375M
| $1.84M | 0.34% |
19,300
-27,100
| -58% | -$2.58M |
|